Net income 2017
Net income 2018
P/E ratio 2017
P/E ratio 2018
EV / Sales2017
EV / Sales2018
5 750 M
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery.It operates its business through the Ionis Core and Akea Therapeutics segments.The Ionis Core segment involves a a novel drug discovery platform generate a broad pipeline of drugs.The Akea...
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating :
Investor Rating :
Latest news on ISIS PHARMACEUTICALS, INC.
Sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC.
Chart ISIS PHARMACEUTICALS, INC.
Number of Analysts
Average target price
Spread / Average Target